Results from a key Canadian study into venoplasty for MS appear to have been prematurely released, leaving questions
Tag Archives: MS
A new ‘cure’ for MS? Not so fast.
The stem cell treatment for MS greeted as a “cure” is a breakthrough for five per cent of people with MS. What about the other 95 per cent?
Why MS scientists are taking aim at Canada’s new science minister
Anne Kingston on how the criticism levelled at Kirsty Duncan over a controversial MS treatment is surprisingly unscientific
Are we on the cusp of a revolution in how we understand the brain?
Two new studies suggest a potential game-changer in how scientists understand of the brain, which could advance research on MS and Alzheimer’s
Shorter CCSVI explainer: Time to liberate liberation treatment
Last week’s shut-down of the Albany, NY clinical trial investigating CCSVI treatment due to lack of patient enrollment is a big set-back on a number of fronts. It’s bad news for the Saskatchewan government, which allocated $2.2 million and recruited patients to travel to the U.S.—and a blow for those who’d taken part in the trial or were lined up to go. But, like all failures, it’s instructive.
Time to liberate ‘liberation’ therapy from MS
Anne Kingston explains why we’ve reached the WTF moment in CCSVI research
The only thing liberated was their wallets
Patients are left with costs as discredited MS therapy circles the drain, writes Colby Cosh
Hurry up and wait for a CCSVI strategy
MS drugs get fast-tracked all the time. Why can’t a clinical trial get the same treatment?
Liberation therapy: the ‘wave of complications’ breaks
Zamboni’s research almost certainly has to have been junk
Good news, bad news: June 30 – July 7, 2011
The Canadian military heads for the far North while Manitobans stare at a massive bill for flood cleanup.